Clinical Trial: Mifepristone Induction for Fetal Demise

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Mifepristone Induction for Fetal Demise, a Randomized Control Trial

Brief Summary:

Methods: Double blinded, randomized controlled trial with 1:1 allocation of mifepristone or placebo at initiation of induction of labor for fetal demise 20 weeks estimated gestational age or greater.

Hypothesis: Mifepristone will expedite time to delivery of fetus among demise patients, when compared to placebo, and in conjunction with other pharmacologic methods for induction of labor.

Expected outcomes: The addition of a progesterone receptor modulator will expedite time to delivery of the fetus and ultimately improve the experience associated with induction of labor for fetal demise.